u/sofia_danquah

ask which facility, then ask for their testing

Careful — that is a claim about efficacy and there is essentially no human evidence behind it.

not approved anywhere, and the boards forget that constantly

dario_boateng is right that biopsy and imaging endpoints are not interchangeable.

Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.

axis labels included, always

Net peptide content is the fraction of the powder that is actually peptide once counterion, water and residual solvent are accounted for. A 99% pure acetate salt can still be about 85% peptide by mass.

Stocked lines and made-to-order lines have different lead times and different storage histories.

This is the rule for anything unusual. Identity before anything else.

20mg into 2mL is 10mg/mL, and 0.5mg of that is 5 units

dead space in the needle hub is real and it is small

Imaging-derived liver fat fraction is a surrogate. It correlates with histology imperfectly, and a trial reporting one is not reporting the other.

Are you accounting for the powder volume, or is that where the confusion is?

Batch number and date of analysis, are both on there?

503A is patient-specific, 503B is outsourcing facility, they are not the same thing

That is the catalogue certificate rather than the batch-specific one. Same layout, completely different status.

That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.

declared value and description are the shipper’s decision, ask what they use

Disagree that a lower number is automatically worse. A conservative claim that survives testing is worth more than an optimistic one that does not.

That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.

Asked for potency testing on the finished preparation.

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

post the whole document, not the headline number

Right, and the concentration genuinely can differ from the branded product, which breaks people’s arithmetic.

a secretagogue and a fragment are not the same class of thing

Pushing back a little: a missing field is usually presentation, not concealment. Ask for the full document before drawing conclusions.

going up too fast is the most repeated regret on this board

Yes. The structure of the document matters at least as much as the number printed on it.

Escalating faster than the schedule allows is the most frequently described regret on the site, and the mechanism is straightforward: tolerance is the limiting factor and it does not care about impatience.

Pushing back a little: a missing field is usually presentation, not concealment.

low_appetite_lisa has the distinction right — one is a fraction of the detector signal, the other is a fraction of the mass.

What reference standard was the assay run against?

a certificate with no method line is decorative

Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.

That figure is the starting material purity, not the finished preparation potency. Two different tests.

Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.

no tracking numbers, ever

I would not read the price difference as a quality signal. Most of it is the consultation model, not the vial.

area% is not mass%, and the difference is the whole game

Area percent or net peptide content? They answer different questions.

Pushing back a little: a missing field is usually presentation, not concealment. Ask for the full document before drawing conclusions.

Not convinced. Imaging-based fat fraction is not the same as a histological response and the paper is explicit about that.

Yes — asking which facility, by name, is the single most useful question and most clinics will answer it.

Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.